S.‐H.I. Ou

Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001

A. Shaw, G.J. Riely, Yung‐Jue Bang et al. · Annals of Oncology · 2019 · 577 citations · Full text

Medicine, Oncology, Pharmacology +13

Prognostic factors for survival of stage I nonsmall cell lung cancer patients

S.‐H.I. Ou, Jason A. Zell, Argyrios Ziogas et al. · Cancer · 2007 · 220 citations

Medicine, Oncology, Chemotherapy +16

KRYSTAL-1: Activity and Safety of Adagrasib (MRTX849) in Advanced/ Metastatic Non–Small-Cell Lung Cancer (NSCLC) Harboring KRAS G12C Mutation

Pasi A. Jänne, Igor I. Rybkin, Alexander I. Spira et al. · European Journal of Cancer · 2020 · 140 citations

Medicine, Oncology, Pharmacology +12

Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status

S.‐H.I. Ou, Jason A. Zell, Argyrios Ziogas et al. · Cancer · 2008 · 98 citations · Full text

Medicine, Oncology, Surgery +17

FP07.12 Underdiagnosis of EGFR Exon 20 Insertion Mutation Variants: Estimates from NGS-based Real-World Datasets

Joshua Bauml, Santiago Viteri, Anna Minchom et al. · Journal of Thoracic Oncology · 2021 · 41 citations

Life Sciences, Genetics, Molecular Genetics +17